These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8721949)

  • 21. Linkage study of the glucagon receptor gene with type 2 diabetes mellitus in Italians.
    Gragnoli C; Milord E; Habener JF
    Metabolism; 2005 Jun; 54(6):786-7. PubMed ID: 15931615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization of the rat genes encoding glucagon, glucagon receptor, and insulin receptor, candidates for diabetes mellitus susceptibility loci.
    Szpirer C; Szpirer J; Vanvooren P; Rivière M; Maget B; Svoboda M; Shiozawa M; Simon JS; Jacob HJ; Koike G
    Mamm Genome; 1997 Aug; 8(8):586-8. PubMed ID: 9250867
    [No Abstract]   [Full Text] [Related]  

  • 23. First proof of pharmacology in humans of a novel glucagon receptor antisense drug.
    van Dongen MG; Geerts BF; Morgan ES; Brandt TA; de Kam ML; Romijn JA; Cohen AF; Bhanot S; Burggraaf J
    J Clin Pharmacol; 2015 Mar; 55(3):298-306. PubMed ID: 25197025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular genetics of non insulin dependent diabetes mellitus].
    Vidal-Puig A; Bjørbaek C
    Med Clin (Barc); 1997 Jun; 109(3):107-14. PubMed ID: 9289511
    [No Abstract]   [Full Text] [Related]  

  • 25. Probability and complex disease genes.
    Ghosh S
    Nat Genet; 1995 Mar; 9(3):223-4. PubMed ID: 7773279
    [No Abstract]   [Full Text] [Related]  

  • 26. Gly82Ser polymorphism of the receptor of advanced glycation end product gene is not associated with coronary heart disease in Finnish nondiabetic subjects or in patients with type 2 diabetes.
    Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
    Diabetes Care; 2000 Jun; 23(6):864. PubMed ID: 10841016
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-cell loss and glucose induced signalling defects in diabetes mellitus caused by mitochondrial tRNALeu(UUR) gene mutation.
    Oka Y; Katagiri H; Ishihara H; Asano T; Kobayashi T; Kikuchi M
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S98-102. PubMed ID: 8894492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes?
    Blüthner M; Brüntgens A; Schmidt S; Strojek K; Grzeszczak W; Ritz E
    Nephrol Dial Transplant; 1999 Jan; 14(1):56-7. PubMed ID: 10052477
    [No Abstract]   [Full Text] [Related]  

  • 29. Study on the relationship between mitochondrial gene mutation and latent autoimmune diabetes mellitus in adults.
    Cui C; Li Q; Zhang Y; Zhang J
    Chin Med Sci J; 2002 Jun; 17(2):73-6. PubMed ID: 12906157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Association of beta 3-adrenergic receptor gene with obesity in patients with type 2 diabetes mellitus].
    Chen Y; Xu Y; Zhou L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):333-5. PubMed ID: 11769635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of the human muscle glycogen synthase gene.
    Orho M; Nikula-Ijäs P; Schalin-Jäntti C; Permutt MA; Groop LC
    Diabetes; 1995 Sep; 44(9):1099-105. PubMed ID: 7657035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoglycemic Effect of Combined Ghrelin and Glucagon Receptor Blockade.
    Mani BK; Uchida A; Lee Y; Osborne-Lawrence S; Charron MJ; Unger RH; Berglund ED; Zigman JM
    Diabetes; 2017 Jul; 66(7):1847-1857. PubMed ID: 28487437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unpleasant alcohol effect in diabetes associated with 3243 bp mitochondrial tRNALeu(UUR) mutation.
    Suzuki Y; Atsumi Y; Hosokawa K; Taniyama M; Kadowaki T; Oka Y; Tanaka Y; Asahina T; Matsuoka K
    Diabetes Care; 1995 Jun; 18(6):880-1. PubMed ID: 7555519
    [No Abstract]   [Full Text] [Related]  

  • 34. Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus.
    Ringel J; Engeli S; Distler A; Sharma AM
    Biochem Biophys Res Commun; 1999 Jan; 254(2):450-3. PubMed ID: 9918859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GAD antibody in multiplex diabetic pedigrees of Chinese.
    Chen T; Ren Y; Long Y; Zhang X; Yu H; Tian H
    Diabetes Care; 2007 Dec; 30(12):3091-2. PubMed ID: 17878243
    [No Abstract]   [Full Text] [Related]  

  • 36. Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes.
    Ali S; Drucker DJ
    Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E415-21. PubMed ID: 19116373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The frequency of diabetes mellitus in parents of diabetic patients relative to disease type].
    Dumitrescu C; Cheţa D; Lichiardopol R; Străchinariu N; Sântu E; Georgescu M; Cocioabă G; Mincu I
    Med Interne; 1987; 25(4):289-95. PubMed ID: 3423705
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diabetic ketoacidosis with a fatal issue: is it a MODY3 (maturity-onset diabetes of the young type 3)?].
    Dehan C; Tran Van D; Delacour H; Deroudilhe G; Fritsch N; Chiappini J; Dardare E; Gardet V
    Ann Biol Clin (Paris); 2008; 66(2):189-93. PubMed ID: 18390429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternally inherited diabetes and deafness: a diabetic subtype associated with a mutation in mitochondrial DNA.
    Maassen JA; van den Ouweland JM; t Hart LM; Lemkes HH
    Horm Metab Res; 1997 Feb; 29(2):50-5. PubMed ID: 9105898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A genetic analysis of diabetes mellitus].
    Atramentova LA; Shtandel' SA
    Tsitol Genet; 1995; 29(3):62-6. PubMed ID: 7676510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.